CPT® Code 0566T

Autologous cellular implant derived from adipose tissue for the treatment of osteoarthritis of the knees; injection of cellular implant into knee joint including ultrasound guidance, unilateral

The procedure described by CPT® Code 0566T involves the use of an autologous cellular implant derived from adipose tissue specifically for the treatment of osteoarthritis of the knees. Osteoarthritis is a prevalent chronic condition characterized by the degeneration of joint cartilage, leading to symptoms such as swelling, stiffness, and pain in the affected joints. As the condition progresses, it can result in the formation of bone spurs within the knee joint, exacerbated by the presence of cytokines and enzymes that further contribute to cartilage degradation. This innovative procedure represents a form of regenerative therapy aimed at alleviating the symptoms of knee osteoarthritis through the injection of the patient's own adipose tissue. The adipose tissue is harvested from the patient, typically through a process known as subcutaneous liposuction, which can be performed on various areas of the body where excess fat is present, such as the abdomen, flank, or thigh. The harvested tissue is then processed to extract mesenchymal stem cells, which are known for their regenerative properties. This is significant because adipose tissue contains a higher concentration of these stem cells compared to other sources, such as bone marrow. The procedure not only involves the injection of the processed adipose tissue into the knee joint but also includes ultrasound guidance to ensure accurate placement of the cellular implant. This method aims to promote healing and potentially restore function in the knee joint affected by osteoarthritis.